Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Visually directed high-intensity focused ultrasound for organ-confined prostate cancer: A proposed standard for the conduct of therapy.

Illing RO, Leslie TA, Kennedy JE, Calleary JG, Ogden CW, Emberton M.

BJU Int. 2006 Dec;98(6):1187-92.

2.

Visually directed high-intensity focused ultrasound for organ-confined prostate cancer: a proposed standard for the conduct of therapy.

Rajpal SL, Campbell IM, Collins GN, O'Reilly PH, Brown SC.

BJU Int. 2007 Apr;99(4):942-3. No abstract available.

4.

Results of high intensity focused ultrasound treatment of prostate cancer: early Canadian experience at a single center.

Elterman DS, Barkin J, Radomski SB, Fleshner NE, Liu B, Bensimon K, Arora S, Robinette M, Finelli A.

Can J Urol. 2011 Dec;18(6):6037-42.

PMID:
22166332
5.

Single-session primary high-intensity focused ultrasonography treatment for localized prostate cancer: biochemical outcomes using third generation-based technology.

Pinthus JH, Farrokhyar F, Hassouna MM, Woods E, Whelan K, Shayegan B, Orovan WL.

BJU Int. 2012 Oct;110(8):1142-8. doi: 10.1111/j.1464-410X.2012.10945.x. Epub 2012 Feb 28.

6.

High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure.

Blana A, Brown SC, Chaussy C, Conti GN, Eastham JA, Ganzer R, Murat FJ, Pasticier G, Rebillard X, Rewcastle JC, Robertson CN, Thuroff S, Ward JF.

BJU Int. 2009 Oct;104(8):1058-62. doi: 10.1111/j.1464-410X.2009.08518.x. Epub 2009 Apr 17.

7.

Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes.

Pfeiffer D, Berger J, Gross AJ.

BJU Int. 2012 Dec;110(11):1702-7. doi: 10.1111/j.1464-410X.2012.11375.x. Epub 2012 Aug 29.

8.
9.

HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.

Asimakopoulos AD, Miano R, Virgili G, Vespasiani G, Finazzi Agrò E.

Urol Oncol. 2012 Sep;30(5):577-83. doi: 10.1016/j.urolonc.2010.08.019. Epub 2011 Feb 2.

PMID:
21292508
10.

Short-term outcome after high-intensity focused ultrasound in the treatment of patients with high-risk prostate cancer.

Ficarra V, Antoniolli SZ, Novara G, Parisi A, Fracalanza S, Martignoni G, Artibani W.

BJU Int. 2006 Dec;98(6):1193-8.

11.

High-intensity focused ultrasound for prostate cancer: a systematic review.

Lukka H, Waldron T, Chin J, Mayhew L, Warde P, Winquist E, Rodrigues G, Shayegan B; Genitourinary Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care.

Clin Oncol (R Coll Radiol). 2011 Mar;23(2):117-27. doi: 10.1016/j.clon.2010.09.002. Epub 2010 Oct 6. Review.

PMID:
20932728
12.

Neoadjuvant hormonal therapy does not impact the treatment success of high-intensity focused ultrasound for the treatment of localized prostate cancer.

Fujisue Y, Azuma H, Inamoto T, Komura K, Agarwal PK, Masuda H, Watsuji T, Katsuoaka Y.

World J Urol. 2011 Oct;29(5):689-94. doi: 10.1007/s00345-010-0628-1. Epub 2010 Dec 16.

PMID:
21161537
13.

[Transrectal high-intensity focused ultrasound with the Sonablate 500 for the treatment of prostate cancer].

Lu J, Chen ZY, Wang W, Zhang YF, Qiu XF, Zhang LC, Hu WL, Xu WF, Ye ZQ.

Zhonghua Nan Ke Xue. 2007 Nov;13(11):1005-8. Chinese.

PMID:
18077913
14.

Transrectal high-intensity focused ultrasound for treatment of localized prostate cancer.

Inoue Y, Goto K, Hayashi T, Hayashi M.

Int J Urol. 2011 May;18(5):358-62. doi: 10.1111/j.1442-2042.2011.02739.x. Epub 2011 Mar 30.

15.

High-intensity focused ultrasound therapy for clinically localized prostate cancer.

Lee HM, Hong JH, Choi HY.

Prostate Cancer Prostatic Dis. 2006;9(4):439-43. Epub 2006 Jul 18.

PMID:
16847468
16.

Treatment of localized prostate cancer using high-intensity focused ultrasound.

Uchida T, Ohkusa H, Nagata Y, Hyodo T, Satoh T, Irie A.

BJU Int. 2006 Jan;97(1):56-61.

17.

PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer.

Ganzer R, Rogenhofer S, Walter B, Lunz JC, Schostak M, Wieland WF, Blana A.

Eur Urol. 2008 Mar;53(3):547-53. Epub 2007 Jul 17.

PMID:
17662520
18.

High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer.

Cordeiro ER, Cathelineau X, Thüroff S, Marberger M, Crouzet S, de la Rosette JJ.

BJU Int. 2012 Nov;110(9):1228-42. doi: 10.1111/j.1464-410X.2012.11262.x. Epub 2012 Jun 6. Review.

19.

Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer: a multicenter study.

Uchida T, Baba S, Irie A, Soh S, Masumori N, Tsukamoto T, Nakatsu H, Fujimoto H, Kakizoe T, Ueda T, Ichikawa T, Ohta N, Kitamura T, Sumitomo M, Hayakawa M, Aoyagi T, Tachibana M, Ikeda R, Suzuki K, Tsuru N, Suzuki K, Ozono S, Fujimoto K, Hirao Y, Monden K, Nasu Y, Kumon H, Nishi K, Ueda S, Koga H, Naitoh S.

Hinyokika Kiyo. 2005 Oct;51(10):651-8.

20.

Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.

Cirillo S, Petracchini M, D'Urso L, Dellamonica P, Illing R, Regge D, Muto G.

BJU Int. 2008 Aug;102(4):452-8. doi: 10.1111/j.1464-410X.2008.07633.x. Epub 2008 May 12.

Supplemental Content

Support Center